NO20073144L - Fremgangsmate for fremstilling av oksazoler ved kondensering av aromatiske aldehyder med alfa-ketoksimer til n-oksider og etterfolggende reaksjon med aktiverte syrederivater - Google Patents
Fremgangsmate for fremstilling av oksazoler ved kondensering av aromatiske aldehyder med alfa-ketoksimer til n-oksider og etterfolggende reaksjon med aktiverte syrederivaterInfo
- Publication number
- NO20073144L NO20073144L NO20073144A NO20073144A NO20073144L NO 20073144 L NO20073144 L NO 20073144L NO 20073144 A NO20073144 A NO 20073144A NO 20073144 A NO20073144 A NO 20073144A NO 20073144 L NO20073144 L NO 20073144L
- Authority
- NO
- Norway
- Prior art keywords
- oxazoles
- ketoxymers
- condensation
- oxides
- preparation
- Prior art date
Links
- 150000002916 oxazoles Chemical class 0.000 title abstract 4
- 239000002253 acid Substances 0.000 title abstract 3
- 238000009833 condensation Methods 0.000 title abstract 3
- 230000005494 condensation Effects 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 238000002360 preparation method Methods 0.000 title abstract 3
- 150000003934 aromatic aldehydes Chemical class 0.000 title abstract 2
- 150000001204 N-oxides Chemical class 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 150000001299 aldehydes Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/36—One oxygen atom
- C07D263/40—One oxygen atom attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/36—One oxygen atom
- C07D263/42—One oxygen atom attached in position 5
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004060227A DE102004060227B3 (de) | 2004-12-15 | 2004-12-15 | Verfahren zur Herstellung von Oxazolen durch Kondensation von aromatischen Aldehyden mit α-Ketoximen zu N-Oxiden und nachfolgende Reaktion mit aktivierten Säurederivaten |
| PCT/EP2005/012800 WO2006066694A1 (fr) | 2004-12-15 | 2005-12-01 | Procede de fabrication d'oxazoles par condensation d'aldehydes aromatiques avec des $g(a)-cetoximes afin de produire des n-oxydes et reaction consecutive avec des derives d'acide actives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20073144L true NO20073144L (no) | 2007-09-11 |
Family
ID=36064837
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20073144A NO20073144L (no) | 2004-12-15 | 2007-06-19 | Fremgangsmate for fremstilling av oksazoler ved kondensering av aromatiske aldehyder med alfa-ketoksimer til n-oksider og etterfolggende reaksjon med aktiverte syrederivater |
Country Status (19)
| Country | Link |
|---|---|
| US (3) | US7544809B2 (fr) |
| EP (1) | EP1828149B1 (fr) |
| JP (1) | JP2008523124A (fr) |
| KR (1) | KR20070089165A (fr) |
| CN (1) | CN101080398A (fr) |
| AR (1) | AR052267A1 (fr) |
| AU (1) | AU2005318635A1 (fr) |
| BR (1) | BRPI0519918A2 (fr) |
| CA (1) | CA2590494A1 (fr) |
| DE (1) | DE102004060227B3 (fr) |
| MA (1) | MA29094B1 (fr) |
| MX (1) | MX2007006676A (fr) |
| NO (1) | NO20073144L (fr) |
| NZ (1) | NZ555670A (fr) |
| RU (1) | RU2402537C2 (fr) |
| TW (1) | TW200635907A (fr) |
| UY (1) | UY29257A1 (fr) |
| WO (1) | WO2006066694A1 (fr) |
| ZA (1) | ZA200704027B (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7816385B2 (en) * | 2002-12-20 | 2010-10-19 | High Point Pharmaceuticals, Llc | Dimeric dicarboxylic acid derivatives, their preparation and use |
| DE102004060227B3 (de) * | 2004-12-15 | 2006-07-20 | Sanofi-Aventis Deutschland Gmbh | Verfahren zur Herstellung von Oxazolen durch Kondensation von aromatischen Aldehyden mit α-Ketoximen zu N-Oxiden und nachfolgende Reaktion mit aktivierten Säurederivaten |
| JP5855095B2 (ja) | 2010-06-07 | 2016-02-09 | ノボメディックス, エルエルシーNovomedix, Llc | フラニル化合物およびその使用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5036079A (en) * | 1989-12-07 | 1991-07-30 | Pfizer Inc. | Hypoglycemic thiazolidinedione derivatives |
| US7176224B2 (en) * | 2000-08-23 | 2007-02-13 | Eli Lilly And Company | Oxazolyl-aryloxyacetic acid derivatives and their use as PPAR agonists |
| MXPA03010903A (es) * | 2001-06-07 | 2004-02-17 | Lilly Co Eli | Moduladores de receptores activados por el proliferador de peroxisomas. |
| DE10308353A1 (de) * | 2003-02-27 | 2004-12-02 | Aventis Pharma Deutschland Gmbh | Diarylcycloalkylderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| DE10308355A1 (de) * | 2003-02-27 | 2004-12-23 | Aventis Pharma Deutschland Gmbh | Aryl-cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel |
| DE102004060227B3 (de) * | 2004-12-15 | 2006-07-20 | Sanofi-Aventis Deutschland Gmbh | Verfahren zur Herstellung von Oxazolen durch Kondensation von aromatischen Aldehyden mit α-Ketoximen zu N-Oxiden und nachfolgende Reaktion mit aktivierten Säurederivaten |
-
2004
- 2004-12-15 DE DE102004060227A patent/DE102004060227B3/de not_active Expired - Fee Related
-
2005
- 2005-12-01 KR KR1020077013519A patent/KR20070089165A/ko not_active Application Discontinuation
- 2005-12-01 BR BRPI0519918-2A patent/BRPI0519918A2/pt not_active IP Right Cessation
- 2005-12-01 WO PCT/EP2005/012800 patent/WO2006066694A1/fr active Application Filing
- 2005-12-01 MX MX2007006676A patent/MX2007006676A/es active IP Right Grant
- 2005-12-01 AU AU2005318635A patent/AU2005318635A1/en not_active Abandoned
- 2005-12-01 NZ NZ555670A patent/NZ555670A/en not_active IP Right Cessation
- 2005-12-01 JP JP2007545880A patent/JP2008523124A/ja not_active Abandoned
- 2005-12-01 EP EP05817378.2A patent/EP1828149B1/fr active Active
- 2005-12-01 CA CA002590494A patent/CA2590494A1/fr not_active Abandoned
- 2005-12-01 CN CNA2005800431232A patent/CN101080398A/zh active Pending
- 2005-12-01 RU RU2007126844/04A patent/RU2402537C2/ru not_active IP Right Cessation
- 2005-12-13 TW TW094143957A patent/TW200635907A/zh unknown
- 2005-12-13 AR ARP050105212A patent/AR052267A1/es not_active Application Discontinuation
- 2005-12-20 UY UY29257A patent/UY29257A1/es unknown
-
2007
- 2007-05-18 ZA ZA200704027A patent/ZA200704027B/en unknown
- 2007-05-29 US US11/754,477 patent/US7544809B2/en active Active
- 2007-06-12 MA MA29988A patent/MA29094B1/fr unknown
- 2007-06-19 NO NO20073144A patent/NO20073144L/no not_active Application Discontinuation
- 2007-10-30 US US11/928,117 patent/US20080114035A1/en not_active Abandoned
-
2009
- 2009-07-27 US US12/509,853 patent/US7825144B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU2005318635A1 (en) | 2006-06-29 |
| RU2402537C2 (ru) | 2010-10-27 |
| CN101080398A (zh) | 2007-11-28 |
| UY29257A1 (es) | 2006-07-31 |
| KR20070089165A (ko) | 2007-08-30 |
| ZA200704027B (en) | 2008-07-30 |
| AR052267A1 (es) | 2007-03-07 |
| DE102004060227B3 (de) | 2006-07-20 |
| EP1828149B1 (fr) | 2015-01-21 |
| US7825144B2 (en) | 2010-11-02 |
| EP1828149A1 (fr) | 2007-09-05 |
| US20080058529A1 (en) | 2008-03-06 |
| US20080114035A1 (en) | 2008-05-15 |
| TW200635907A (en) | 2006-10-16 |
| WO2006066694A1 (fr) | 2006-06-29 |
| US20090286988A1 (en) | 2009-11-19 |
| NZ555670A (en) | 2010-09-30 |
| MX2007006676A (es) | 2007-08-14 |
| RU2007126844A (ru) | 2009-01-27 |
| JP2008523124A (ja) | 2008-07-03 |
| BRPI0519918A2 (pt) | 2009-04-07 |
| MA29094B1 (fr) | 2007-12-03 |
| US7544809B2 (en) | 2009-06-09 |
| CA2590494A1 (fr) | 2006-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20085064L (no) | 4,5-difenyl-pyrimidinyl-oksy eller -merkaptosubstituerte karboksylsyrer, fremgangsmate for deres fremstilling og anvendelse derav som medikamenter | |
| NO20085066L (no) | 4,5-difenyl-pyrimidinyl-aminosubstituerte karboksylsyrer, fremgangsmate for deres fremstilling og anvendelse derav som medikamenter | |
| WO2009145456A3 (fr) | Dérivés hétérocycliques | |
| NO20076066L (no) | Oksadiazolderivater som DGAT-inhibitorer | |
| NO20085067L (no) | 4,5-difenyl-pyrimidinyl substituerte karboksylsyrer, fremgangsmate for deres fremstilling og anvendelse derav som medikamenter | |
| NO20056010L (no) | Biaryloksymetylaren-karboksylsyrer | |
| NO20085121L (no) | Benzimidazolderivater, deres fremstillingsmate, deres anvendelse som FXR-agonister og farmasoytiske blandinger inneholdende samme | |
| NO20071242L (no) | Triazolpyridinylsulfanylderivater som P38-MAP-kinaseinhibitorer | |
| NO20090139L (no) | Substituted phenyl acetic acids as DP-2 antagonists | |
| NO20085169L (no) | Krystallinske solvater og komplekser av (1S)-1,5-anhydro-L-C- (3-((fenyl)metyl)fenyl)-D-glucitol derivater med aminosyrer som SGLT2-inhibitorer for behandling av diabetes | |
| NO20075626L (no) | Heteroarylbenzamid-derivater for anvendelse som GLK-aktivatorer i behandling av diabetes | |
| WO2009100872A8 (fr) | Dérivés d’urée de benzomorphanes et structures associées, médicaments contenant de tels composés et leur utilisation | |
| NO20080675L (no) | P38-Map kinaseinhibitorer og metoder for deres anvendelse | |
| NO20080897L (no) | Salter av 4-metyl-N-[3-(4-metylimidazol-1-yl)-5-trifluormetylfenyl]-3-(4-pyridin-3-ylpyrimidin-2-ylamino)benzamid | |
| NO20076648L (no) | Novel thiophene derivatives | |
| NO20084850L (no) | MGLUR5 modulatorer I | |
| WO2007106469A3 (fr) | Derives bicycliques de l'acide carboxylique utiles dans le traitement de troubles metaboliques | |
| NO20076658L (no) | Heteroarylbenzamidderivater for anvendelse som GLK aktivatorer ved behandling av diabetes | |
| ATE432260T1 (de) | Pyridinderivate als pkc-theta-hemmer | |
| WO2008083950A8 (fr) | Dérivés spirocycliques de l'acide tétronique | |
| NO20091025L (no) | Arylsulfonamider med analgesisk virkning | |
| NO20080394L (no) | N-(arylalkyl)-1H-pyrrolopyridin-2-karboksamidderivater, fremstilling og anvendelse derav | |
| NO20090138L (no) | Substituted phenyl acetic acids as DP-2 antagonists | |
| NO20084301L (no) | Tetrahydronaftalenderivater, fremgangsmate for deres fremstilling og anvendelse derav som anti-inflammatoriske midler | |
| ATE523510T1 (de) | Substituierte 4-aryl-1,4-dihydro-1,6- naphthyridine und ihre verwendung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |